EGF and cancer: To this end, a substantial amount of experimental data was utilized, encompassing the ligand-dependent (e.g., EGF, HGF) activation and drug-induced inhibition of intracellular signaling as well as drug-induced regulation of cancer cell viability (covering both time-dependent and dose-dependent features with over 10 drugs).